E. Ohman J or Asset Management AB Has $1.90 Million Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

E. Ohman J or Asset Management AB raised its stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 85.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 61,300 shares of the company's stock after purchasing an additional 28,300 shares during the quarter. E. Ohman J or Asset Management AB owned approximately 0.12% of Astrana Health worth $1,901,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Pilgrim Partners Asia Pte Ltd bought a new position in Astrana Health in the fourth quarter valued at approximately $40,000. Quarry LP grew its stake in Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares in the last quarter. KBC Group NV grew its stake in Astrana Health by 108.4% in the fourth quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after purchasing an additional 1,316 shares in the last quarter. US Bancorp DE grew its stake in Astrana Health by 3,880.0% in the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after purchasing an additional 4,656 shares in the last quarter. Finally, PharVision Advisers LLC bought a new position in Astrana Health in the fourth quarter valued at approximately $211,000. 52.77% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Stifel Nicolaus decreased their price target on Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Robert W. Baird decreased their price target on Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Bank of America reduced their target price on Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research note on Tuesday, March 4th. Barclays initiated coverage on Astrana Health in a research note on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 target price for the company. Finally, Truist Financial reduced their target price on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Astrana Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Stock Performance

ASTH opened at $25.26 on Friday. The business has a fifty day simple moving average of $29.12 and a 200 day simple moving average of $32.94. The company has a market capitalization of $1.42 billion, a PE ratio of 19.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.85. Astrana Health, Inc. has a 1 year low of $23.12 and a 1 year high of $63.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09). The firm had revenue of $620.39 million during the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business's revenue for the quarter was up 53.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.31 earnings per share. Research analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.